AVITA Medical (RCEL) Receivables (2019 - 2025)
Historic Receivables for AVITA Medical (RCEL) over the last 7 years, with Q4 2025 value amounting to $9.1 million.
- AVITA Medical's Receivables fell 2290.85% to $9.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $9.1 million, marking a year-over-year decrease of 2290.85%. This contributed to the annual value of $9.1 million for FY2025, which is 2327.31% down from last year.
- Per AVITA Medical's latest filing, its Receivables stood at $9.1 million for Q4 2025, which was down 2290.85% from $9.0 million recorded in Q3 2025.
- AVITA Medical's 5-year Receivables high stood at $12.0 million for Q1 2025, and its period low was $3.4 million during Q4 2021.
- Its 5-year average for Receivables is $7.1 million, with a median of $6.6 million in 2023.
- In the last 5 years, AVITA Medical's Receivables surged by 20439.97% in 2021 and then crashed by 4296.91% in 2022.
- AVITA Medical's Receivables (Quarter) stood at $3.4 million in 2021, then rose by 28.81% to $4.4 million in 2022, then skyrocketed by 74.35% to $7.7 million in 2023, then soared by 53.18% to $11.8 million in 2024, then fell by 22.91% to $9.1 million in 2025.
- Its Receivables was $9.1 million in Q4 2025, compared to $9.0 million in Q3 2025 and $11.3 million in Q2 2025.